TAMMY BAKER: Open Payments
NPI 1922035062 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 9 payments from 8 companies in 2025. Trend: 2023 $831 · 2024 $680 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| ABIOMED | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: WATCHMAN FLX, WAINUA, OPSUMIT, CAMZYOS, NEXLETOL, LEQVIO, INSPIRE.
Industry payments across PA — which companies pay providers there.
